Requests a comprehensive assessment and report on substance use disorder treatment capacity and needs statewide
Impact
Upon implementation, HCR45 aims to enhance the overall treatment capacity for substance use disorders in Louisiana by directing efforts towards the areas and populations most in need. The office of behavioral health will evaluate both outpatient and residential treatment options, facilitating a preventative approach to addiction and overall public health. This resolution suggests a shift in public policy, emphasizing the importance of thorough assessments to guide future investments in treatment services and potentially influence Medicaid funding strategies for substance use disorder treatment.
Summary
HCR45 is a concurrent resolution urging the Louisiana Department of Health's office of behavioral health to conduct a comprehensive assessment of the state's capacity and needs concerning substance use disorder treatment. The resolution acknowledges the devastating effects of untreated substance use disorders, particularly in light of the ongoing opioid crisis, which has worsened during the COVID-19 pandemic. By understanding current treatment capacity and unmet needs, the resolution seeks to inform policymakers to strategically allocate resources where they are most needed.
Sentiment
The general sentiment surrounding HCR45 appears to be positive, with broad support for addressing the ongoing substance use disorder issues in the state. Stakeholders acknowledge the necessity of such assessments to improve treatment offerings and gauge the effectiveness of current services. While there may be some concern regarding the efficient implementation of recommendations, the resolution is fundamentally viewed as a proactive measure to combat the growing addiction crisis in Louisiana.
Contention
Although HCR45 underscores the need for better assessment and resources for treating substance use disorders, there may be contention regarding the specific methods of data collection and the allocation of treatment resources following the assessment. Engaging various stakeholders, including treatment providers and state agencies, is essential for the resolution's success, but disagreements may arise over which populations should receive priority treatment and how resources should be distributed. Clarity on addressing the needs of vulnerable groups, such as adolescents and women with children, will be crucial in determining the overall effectiveness of the proposed measures.
Substance use disorder comprehensive assessment requirements and treatment provider qualifications modified, and study and report on substance use disorder treatment practice limitations required.
Requesting The Department Of Health To Assess The Services And Funding Necessary To Address The Needs Of Complex Patients Who Have Two Or More Diagnoses That Include Substance Use Disorders, Mental Health Disorders, Or Chronic Physical Illnesses.
Substance use disorder comprehensive assessment requirements and treatment provider qualifications modified, and study and report on substance use disorder treatment practice limitations required.
Requesting The Department Of Health To Convene A Complex Needs Patient Working Group To Address The Needs, Services, And Funding For Complex Needs Patients Who Have Multiple Significant But Not Severe Diagnoses Of Chronic Conditions, Including Substance Use Disorders, Mental Health Disorders, Or Chronic Physical Illness Conditions.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.